Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
The Breast Journal|May 20, 2003
A roundtable discussion of aromatase inhibitors as therapy for breast cancerD Craig Allred, Michael Baum, Aman U Buzdar, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 18, 2012
The heritability of mammographic breast density and circulating sex-hormone levels: two independent breast cancer risk factorsJajini S Varghese, Paula L Smith, Elizabeth Folkerd, et al.Journal of Proteome Research|April 5, 2008
Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MSMelinda E Sanders, Eduardo C Dias, Baogang J Xu, et al.Archives of Pathology & Laboratory Medicine|June 12, 2023
Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerAntonio C Wolff, Mark R Somerfield, Mitchell Dowsett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2023
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline UpdateAntonio C Wolff, Mark R Somerfield, Mitchell Dowsett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention TrialsJack Cuzick, Adam R Brentnall, Corrinne Segal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Research issues affecting preoperative systemic therapy for operable breast cancerAntonio C Wolff, Donald Berry, Lisa A Carey, et al.Journal of Clinical Pathology|December 15, 2010
Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancerRobin L Jones, Federico Rojo, Roger A'Hern, et al.Cancer Research|August 15, 2009
Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factorsKate Walker, Olivia Fletcher, Nichola Johnson, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 4, 2017
RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, Linda Ashcroft, Lesley Fallowfield, et al.Pageof 5